Adamas Pharma Stock Price, News & Analysis

ADMS NASDAQ

Company Description

Adamas Pharma (NASDAQ: ADMS) is a publicly traded pharmaceutical preparation manufacturing company in the Manufacturing sector.

ADMS stock has gained 91.6% over the past year.

This page provides a comprehensive overview of ADMS stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart

$—

0.00%

0.00

Last updated:

+91.61%

Performance 1 year

$0.0

Market Cap

45.8M

Shares outstanding

Adamas Pharma (ADMS) stock. Over the past 12 months, the stock has gained 91.6%.

Latest News

View All

October 8, 2021

+75.05%

Adamas Announces New Employment Inducement Grants

October 1, 2021

-3.05%

Adamas Named 2021 Finalist in the New Therapeutics Category of the UCSF Health Awards

September 16, 2021

+2.15%

Adamas Announces GOCOVRI Presentations at the Upcoming International Parkinson and Movement Disorder Society’s (MDS) Congress

September 10, 2021

+0.22%

Adamas Announces New Employment Inducement Grants

August 30, 2021

+3.97%

Adamas to Present at Upcoming September Investor Conferences

conferences

August 13, 2021

-7.56%

Adamas Announces New Employment Inducement Grant

Adamas Pharma has 10 recent news articles. Of the recent coverage, 5 articles coincided with positive price movement and 5 with negative movement. Key topics include conferences, earnings. View all ADMS news →

SEC Filings

View All

No SEC filings available for ADMS.

Financial Highlights

View Full Financials

—

Revenue (TTM)

—

Net Income (TTM)

—

Diluted EPS (TTM)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

ADMS Company Profile & Sector Positioning

Adamas Pharma (ADMS) operates in the Pharmaceutical Preparation Manufacturing industry within the broader Manufacturing sector and is listed on the NASDAQ.